We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessment and Authentication of Promea Therapeutic's Indigenous Digital Hemoglobin Analyzer (Dr. Protech H+).
- Authors
Sachan, Anjali
- Abstract
Haemoglobin estimation is an important screening test for patients. Despite many methods available, each method has some advantages and disadvantages. Hemoglobin estimation by digital Hemoglobin Meter proved to be a very reliable, sophisticated, appropriate and ideal especially for some particular setup like blood donation / premedical screening and also reliable in comparison to hematology analyzer. Materials and Methods: A study of 350 Single donor platelet donors to evaluate a Promea's Digital Hemoglobin Analyzer (Dr. Protech H+) was done in a laboratory from November 2022 to December 2022.and data were compared to Sysmex KX 21 cell counter which is one of the most accurate methods for Haemoglobin estimation. Out of 350 donors 247 were male and 103 were female. Mean value of Promea's Digital Hemoglobin Analyzer (Dr. Protech H+) (mean 14.0 g/dl) was slightly lower by 0.2 compared to reference (mean 14.2 g/dl) but not statistically significant. In comparison to cell counter Promea's Digital Hemoglobin Analyzer (Dr. Protech H+) proved to be the cost effective with sensitivity and specificity more than 95%. which indicates high precision. Conclusion: Promea's Digital Hemoglobin Analyzer (Dr. Protech H+) gives comparable results to cell counter and hence proved to be reliable, easy to operate and cost effective.
- Subjects
HEMOGLOBINS; MEDICAL screening; OPERATING costs; BLOOD platelets; SENSITIVITY &; specificity (Statistics)
- Publication
Journal of Drug Delivery & Therapeutics, 2023, Vol 13, Issue 6, p43
- ISSN
2250-1177
- Publication type
Article
- DOI
10.22270/jddt.v13i6.5853